Cargando…
Comparing clinical efficacy of Symbicort versus Pulmicort in reducing asthma symptom and improving its control
BACKGROUND: Recently, higher efficacy of the combination of long-acting beta2-adrenoceptor agonist and inhaled corticosteroids on controlling asthma symptoms has been hypothesized. This study aimed to examine the clinical effects of the combination of Budesonide with formoterol (Symbicort) and Budes...
Autores principales: | Emami, Mohammad, Tayebi, Azadeh, Gharipour, Mojgan, Farzamnia, Somayeh, Temyarti, Akbar Kargari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988601/ https://www.ncbi.nlm.nih.gov/pubmed/24761394 http://dx.doi.org/10.4103/2277-9175.127999 |
Ejemplares similares
-
Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD
por: Giner, Jordi, et al.
Publicado: (2020) -
Utility and effectiveness of Symbicort® Turbuhaler® (oral inhalation containing budesonide and formoterol) in a patient with severe asthma after permanent tracheostomy
por: Maeda, Kohhei, et al.
Publicado: (2018) -
Real-Life Clinical Use of Symbicort® Maintenance and Reliever Therapy for Asthmatic Patients in Korea
por: Kim, Sang-Hoon, et al.
Publicado: (2018) -
The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial
por: Shavakhi, Ahmad, et al.
Publicado: (2014) -
A randomized open-label trial on the use of budesonide/formoterol (Symbicort(®)) as an alternative reliever medication for mild to moderate asthmatic attacks
por: Chew, Keng Sheng, et al.
Publicado: (2012)